Medical Products

Establish an approach to assessing medical product-related healthcare outbreak & response activities

For use by health departments, healthcare facilities, and other affected parties

Prepared by
CORHA logo
Relevant dates
Last updated: November 27, 2024
Published: November 27, 2024

About Medical Products

Medical products, such as devices, drugs, and biologics, play crucial roles in medical diagnosis and treatment. They also present risks. Patient infections can occur when a medical product is contaminated during manufacturing, compounding, storage, preparation, use, or disposal. Outbreaks can occur when groups of patients are exposed to contaminated medical products either in a single facility (as a result of mishandling by healthcare personnel) or across multiple facilities or jurisdictions (for example, when a product is contaminated at the point of manufacture prior to distribution).

Differentiating between intrinsic contamination (occurring before arrival at the point of use facility) and extrinsic contamination (occurring after arrival at point of use facility) is a critical step to determine the scope of an outbreak and appropriate intervention. This typically requires collaboration between healthcare facility, public health, laboratory, and regulatory partners. For more information refer to the CORHA Principles & Practices (see below).

See More Tools to Manage Outbreaks